Kreimer, Aimée R.Chaturvedi, Anil K.Alemany i Vilches, LaiaAnantharaman, DevasenaBray, FreddieCarrington, MaryDoorbar, JohnD'Souza, GypsyamberFakhry, CaroleFerris, Robert L.Gillison, MauraNeil Hayes, D.Hildesheim, AllanHuang, Shao HuiKowalski, Luiz P.Lang Kuhs, Krystle A.Lewis, JamesLowy, Douglas R.Mehanna, HishamNess, AndyPawlita, MichaelPinheiro, MaisaSchiller, JohnShiels, Meredith S.Tota, JosephMirabello, LisaWarnakulasuriya, SamanWaterboer, TimWestra, WilliamChanock, Stephen J.Brennan, Paul2021-03-032021-03-032020-09-01https://hdl.handle.net/2445/174539Cancer of the oropharynx has attracted considerable attention in recent years given: (1) an increasing incidence in selected populations over the past three decades; (2) the discovery of human papillomavirus (HPV) infection as the driver of the increase, as opposed to the traditional risk factors such as tobacco (smoking and chewing) and alcohol; and (3) the promise of new prevention and treatment strategies. As a result of such developments, the International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI), convened the fourth Cancer Seminar meeting in November 2018 to focus on this topic. This report summarizes the proceedings: a review of recent science on the descriptive epidemiology, etiology, biology, genetics, early detection, pathology and treatment of HPV-positive oropharyngeal cancer, and the formulation of key research questions to be addressed.7 p.application/pdfengcc by-nc-nd (c) Kreimer et al., 2020http://creativecommons.org/licenses/by-nc-nd/3.0/es/Càncer de bocaPapil·lomavirusOral cancerPapillomavirusesinfo:eu-repo/semantics/article2021-03-02info:eu-repo/semantics/openAccess32502860